Clindamycin palmitate
Drug ingredientCAS 36688-78-5
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
3 FDA-registered drug labelers
Chongqing Biocare Pharmaceutical Ltd.
Chongqing Bioland Pharmaceutical Ltd.
Pharmacia and Upjohn Company LLC
Why It Matters
Sectors
Health
Downstream UsesNot recorded
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.
- to be discontinued
Clindamycin Palmitate Hydrochloride Injection
Shortage listed since February 27, 2026
Chemical Identity
CAS36688-78-5
PubChem CID16052039
DTXSIDDTXSID20190134
FormulaC34H63ClN2O6S
Mol. Weight663.4 g/mol
SMILESCCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O
Data Sources
- PubChem · compound 16052039Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
Brief citations
Clindamycin palmitate (CAS 36688-78-5) https://chemicalindependence.com/chemical/36688-78-5/ PubChem: 16052039. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/16052039 FDA National Drug Code directory: CAS 36688-78-5. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 36688-78-5. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/